Atea Pharmaceuticals, Inc. (AVIR)
4.11
-0.20
(-4.64%)
USD |
NASDAQ |
Oct 30, 16:00
4.115
0.00 (0.00%)
After-Hours: 20:00
Atea Pharmaceuticals Price to Book Value : 1.615 for Oct. 30, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 30, 2026 | 1.615 |
| October 29, 2026 | 1.693 |
| October 28, 2026 | 1.678 |
| October 27, 2026 | 1.638 |
| October 26, 2026 | 1.634 |
| October 23, 2026 | 1.587 |
| October 22, 2026 | 1.591 |
| October 21, 2026 | 1.603 |
| October 20, 2026 | 1.754 |
| October 19, 2026 | 1.725 |
| October 16, 2026 | 1.697 |
| October 15, 2026 | 1.780 |
| October 14, 2026 | 1.819 |
| October 13, 2026 | 1.956 |
| October 12, 2026 | 1.976 |
| October 09, 2026 | 2.023 |
| October 08, 2026 | 2.025 |
| October 07, 2026 | 1.968 |
| October 06, 2026 | 1.992 |
| October 05, 2026 | 2.015 |
| October 02, 2026 | 2.015 |
| October 01, 2026 | 2.004 |
| September 30, 2026 | 2.047 |
| September 29, 2026 | 2.035 |
| September 28, 2026 | 2.043 |
| Date | Value |
|---|---|
| September 25, 2026 | 2.031 |
| September 24, 2026 | 2.031 |
| September 23, 2026 | 2.074 |
| September 22, 2026 | 2.216 |
| September 21, 2026 | 2.133 |
| September 18, 2026 | 2.094 |
| September 17, 2026 | 2.066 |
| September 16, 2026 | 2.023 |
| September 15, 2026 | 2.055 |
| September 14, 2026 | 2.09 |
| September 11, 2026 | 2.086 |
| September 10, 2026 | 2.035 |
| September 09, 2026 | 2.070 |
| September 08, 2026 | 2.231 |
| September 04, 2026 | 2.290 |
| September 03, 2026 | 2.286 |
| September 02, 2026 | 2.239 |
| September 01, 2026 | 2.157 |
| August 31, 2026 | 2.102 |
| August 28, 2026 | 2.106 |
| August 27, 2026 | 2.141 |
| August 26, 2026 | 2.165 |
| August 25, 2026 | 2.133 |
| August 24, 2026 | 2.165 |
| August 21, 2026 | 2.133 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Filana Therapeutics, Inc. | 0.4724 |
| CorMedix, Inc. | 0.9598 |
| Eloxx Pharmaceuticals, Inc. | 1.170 |
| Breakthrough Chemistry, Inc. | 1.893 |
| BioStem Technologies, Inc. | 0.7228 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0661 |
| Price | 4.11 |
| Earnings Yield | -50.89% |
| Market Cap | 329.64M |
| PEGY Ratio | -0.0661 |